Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-/-) mouse model of infantile hypophosphatasia.

[1]  F. Jakob,et al.  Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia , 2014, European Journal of Human Genetics.

[2]  J. Millán,et al.  In Vivo Overexpression of Tissue‐Nonspecific Alkaline Phosphatase Increases Skeletal Mineralization and Affects the Phosphorylation Status of Osteopontin , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  M. McKee,et al.  Tooth root dentin mineralization defects in a mouse model of hypophosphatasia , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  N. Hatch,et al.  Further Analysis of the Crouzon Mouse: Effects of the FGFR2C342Y Mutation Are Cranial Bone–Dependent , 2013, Calcified Tissue International.

[5]  R. Keating,et al.  Age at Initial Consultation for Craniosynostosis: Comparison Across Different Patient Characteristics , 2013, The Journal of craniofacial surgery.

[6]  J. Millán The Role of Phosphatases in the Initiation of Skeletal Mineralization , 2012, Calcified Tissue International.

[7]  J. Millán,et al.  Enzyme replacement prevents enamel defects in hypophosphatasia mice , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  Nick Bishop,et al.  Enzyme-replacement therapy in life-threatening hypophosphatasia. , 2012, The New England journal of medicine.

[9]  H. Gjørup,et al.  Craniofacial morphology in patients with hypophosphatemic rickets: A cephalometric study focusing on differences between bone of cartilaginous and intramembranous origin , 2011, American journal of medical genetics. Part A.

[10]  N. Hatch,et al.  Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) Protein Regulates Osteoblast Differentiation , 2011, The Journal of Biological Chemistry.

[11]  J. Millán,et al.  Dose response of bone-targeted enzyme replacement for murine hypophosphatasia. , 2011, Bone.

[12]  R. Keating,et al.  Treatment for delayed presentation of sagittal synostosis: challenges pertaining to occult intracranial hypertension. , 2011, Journal of neurosurgery. Pediatrics.

[13]  Jeffrey J. Gray,et al.  Enzyme Replacement Therapy Prevents Dental Defects in a Model of Hypophosphatasia , 2011, Journal of dental research.

[14]  H. Meltzer,et al.  Craniofacial reconstruction as a treatment for elevated intracranial pressure , 2011, Child's Nervous System.

[15]  H. Jo,et al.  Inorganic Phosphate Induces Mammalian Growth Plate Chondrocyte Apoptosis in a Mitochondrial Pathway Involving Nitric Oxide and JNK MAP Kinase , 2011, Calcified Tissue International.

[16]  Ralph Müller,et al.  Guidelines for assessment of bone microstructure in rodents using micro–computed tomography , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  M. Demay,et al.  Phosphate-induced Apoptosis of Hypertrophic Chondrocytes Is Associated with a Decrease in Mitochondrial Membrane Potential and Is Dependent upon Erk1/2 Phosphorylation* , 2010, The Journal of Biological Chemistry.

[18]  M. Whyte Physiological role of alkaline phosphatase explored in hypophosphatasia , 2010, Annals of the New York Academy of Sciences.

[19]  P. Ciancaglini,et al.  Kinetic Analysis of Substrate Utilization by Native and TNAP-, NPP1-, or PHOSPHO1-Deficient Matrix Vesicles , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  S. Goldstein,et al.  Beam hardening artifacts in micro-computed tomography scanning can be reduced by X-ray beam filtration and the resulting images can be used to accurately measure BMD. , 2009, Bone.

[21]  D. David,et al.  Intellectual Outcomes Following Protocol Management in Crouzon, Pfeiffer, and Muenke Syndromes , 2009, The Journal of craniofacial surgery.

[22]  David W Holdsworth,et al.  In vivo micro-CT analysis of bone remodeling in a rat calvarial defect model , 2009, Physics in medicine and biology.

[23]  S. Gattenlöhner,et al.  Neurosurgical aspects of childhood hypophosphatasia , 2009, Child's Nervous System.

[24]  S. Rasmussen,et al.  Priorities for public health research on craniosynostosis: Summary and recommendations from a Centers for Disease Control and Prevention‐sponsored meeting , 2008, American journal of medical genetics. Part A.

[25]  R. Terkeltaub,et al.  Enzyme Replacement Therapy for Murine Hypophosphatasia , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  D. Rice Developmental anatomy of craniofacial sutures. , 2008, Frontiers of oral biology.

[27]  Hristo N Nikolov,et al.  A quality assurance phantom for the performance evaluation of volumetric micro-CT systems , 2007, Physics in medicine and biology.

[28]  B. Bain,et al.  Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres , 2007, British journal of haematology.

[29]  E. Mornet Hypophosphatasia , 2007, Orphanet journal of rare diseases.

[30]  M. McKee,et al.  Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity* , 2007, Journal of Biological Chemistry.

[31]  D. Chitayat,et al.  Sudden infant death in a patient with FGFR3 P250R mutation , 2006, American journal of medical genetics. Part A.

[32]  Daniel Govier,et al.  The Craniofacial Phenotype of the Crouzon Mouse: Analysis of a Model for Syndromic Craniosynostosis Using Three-Dimensional MicroCT , 2006, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

[33]  R. Terkeltaub,et al.  Elevated Skeletal Osteopontin Levels Contribute to the Hypophosphatasia Phenotype in Akp2−/− Mice , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  J. Millán Mammalian Alkaline Phosphatases: From Biology to Applications in Medicine and Biotechnology , 2006 .

[35]  Gillian M Morriss-Kay,et al.  Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies , 2005, Journal of anatomy.

[36]  M. Demay,et al.  Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Terkeltaub,et al.  Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. , 2005, The American journal of pathology.

[38]  A. Weiss,et al.  Progressive Postnatal Craniosynostosis and Increased Intracranial Pressure , 2004, Plastic and reconstructive surgery.

[39]  R. Terkeltaub,et al.  Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. , 2004, The American journal of pathology.

[40]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[41]  R. Terkeltaub,et al.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Eric Arnaud,et al.  Management of craniosynostoses , 2000, Child's Nervous System.

[43]  J. Millán,et al.  Functional Characterization of Osteoblasts and Osteoclasts from Alkaline Phosphatase Knockout Mice , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  R. Terkeltaub,et al.  Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[45]  E. Moran,et al.  Phosphate is a specific signal for induction of osteopontin gene expression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  E. Mornet Hypophosphatasia: The mutations in the tissue‐nonspecific alkaline phosphatase gene , 2000, Human mutation.

[47]  J. Millán,et al.  Alkaline Phosphatase Knock‐Out Mice Recapitulate the Metabolic and Skeletal Defects of Infantile Hypophosphatasia , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[48]  E. Jabs,et al.  Ocular anterior chamber dysgenesis in craniosynostosis syndromes with a fibroblast growth factor receptor 2 mutation. , 1999, American journal of medical genetics.

[49]  V. Everts,et al.  Root Development in Mice Lacking Functional Tissue Non-specific Alkaline Phosphatase Gene: Inhibition of Acellular Cementum Formation , 1999, Journal of dental research.

[50]  R. Baron,et al.  Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. , 1998, Endocrinology.

[51]  R. Baron,et al.  Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  L. Heier,et al.  The role of the cranial base in facial growth: experimental craniofacial synostosis in the rabbit. , 1997, Plastic and reconstructive surgery.

[53]  J. Millán,et al.  Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[54]  T. Guilarte,et al.  Mice lacking tissue non–specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B–6 , 1995, Nature Genetics.

[55]  M. Cohen,et al.  Sutural biology and the correlates of craniosynostosis. , 1993, American journal of medical genetics.

[56]  S. Kreiborg,et al.  Upper and lower airway compromise in the Apert syndrome. , 1992, American journal of medical genetics.

[57]  M. Whyte,et al.  Hypophosphatasia and the extracellular metabolism of inorganic pyrophosphate: clinical and laboratory aspects. , 1991, Critical reviews in clinical laboratory sciences.

[58]  D. Rimoin,et al.  Histologic and ultrastructural studies on the mineralization process in hypophosphatasia. , 1985, American journal of medical genetics.

[59]  D L Parker,et al.  Optimal short scan convolution reconstruction for fanbeam CT. , 1982, Medical physics.

[60]  D. Parker Optimal short scan convolution reconstruction for fan beam CT , 1982 .

[61]  M. Whyte,et al.  Adult hypophosphatasia: generalized deficiency of alkaline phosphatase activity demonstrated with cultured skin fibroblasts. , 1982, Transactions of the Association of American Physicians.

[62]  S. Kreiborg Craniofacial growth in plagiocephaly and Crouzon syndrome. , 1981, Scandinavian journal of plastic and reconstructive surgery.

[63]  M M Cohen,et al.  Perspectives on Craniosynostosis: Sutural Biology, Some Well-known Syndromes, and Some Unusual Syndromes , 1980, The Western journal of medicine.

[64]  A. Sokol The pathogenesis of premature craniosynostosis in acrocephalosyndactyly (Apert's syndrome) , 1978 .

[65]  R. Stewart,et al.  THE PATHOGENESIS OF PREMATURE CRANIOSYNOSTOSIS IN ACROCEPHALOSYNDACTYLY (APERT'S SYNDROME) A Reconsideration , 1977, Plastic and reconstructive surgery.

[66]  F. Glorieux,et al.  Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[67]  B. Reilly,et al.  CRANIOSYNOSTOSIS IN THE RACHITIC SPECTRUM. , 1964, The Journal of pediatrics.